Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002).
about
Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.Multicenter phase II study of combination therapy with cetuximab and S-1 in patients with KRAS exon 2 wild-type unresectable colorectal cancer previously treated with irinotecan, oxaliplatin, and fluoropyrimidines (KSCC 0901 study).Recent advances in treatment for colorectal liver metastasis.
P2860
Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phase II Trial of S-1 and Oxal ...... e Liver Metastases (KSCC1002).
@en
type
label
Phase II Trial of S-1 and Oxal ...... e Liver Metastases (KSCC1002).
@en
prefLabel
Phase II Trial of S-1 and Oxal ...... e Liver Metastases (KSCC1002).
@en
P2093
P2860
P921
P1476
Phase II Trial of S-1 and Oxal ...... e Liver Metastases (KSCC1002).
@en
P2093
Akira Kabashima
Hidefumi Higashi
Hideo Baba
Hiroshi Saeki
Ken Shirabe
Kyushu Study Group of Clinical Cancer (KSCC)
Masahiko Ikebe
Masahiko Sakoda
Mitsuhisa Takatsuki
P2860
P2888
P304
P356
10.1245/S10434-015-4771-1
P478
22 Suppl 3
P577
2015-09-03T00:00:00Z
P5875
P6179
1028919646